Výsledky vyhledávání - Swaminathan P. Iyer

Upřesnit hledání
  1. 1
    Romidepsin for the Treatment of Peripheral T-Cell Lymphoma

    Romidepsin for the Treatment of Peripheral T-Cell Lymphoma Autor Swaminathan P. Iyer, Francine F. Foss

    Vydáno 2015
    Získat plný text Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  2. 2
    Targeting CLL-1 for acute myeloid leukemia therapy

    Targeting CLL-1 for acute myeloid leukemia therapy Autor Hongbing Ma, Swaminathan P. Iyer, Simrit Parmar, Yuping Gong

    Vydáno 2019
    Získat plný text Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  3. 3
    A unique aptamer-drug conjugate for targeted therapy of multiple myeloma

    A unique aptamer-drug conjugate for targeted therapy of multiple myeloma Autor Jia Wen, Wenjing Tao, Suyang Hao, Swaminathan P. Iyer, Youli Zu

    Vydáno 2015
    Získat plný text
    Carta
    Přidat do oblíbených
    Uloženo v:
  4. 4
    Atomic force microscopy detects differences in the surface brush of normal and cancerous cells

    Atomic force microscopy detects differences in the surface brush of normal and cancerous cells Autor Swaminathan P. Iyer, Ravi Gaikwad, Venkatesh Subba-Rao, Craig D. Woodworth, Igor Sokolov

    Vydáno 2009
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  5. 5
    Ofatumumab is active in patients with fludarabine-refractory CLL irrespective of prior rituximab: results from the phase 2 international study

    Ofatumumab is active in patients with fludarabine-refractory CLL irrespective of prior rituximab: results from the phase 2 international study Autor William G. Wierda, Swaminathan P. Iyer, Geoffrey Chan, Ira Gupta, Steen Lisby, Anders Österborg

    Vydáno 2011
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  6. 6
    Oligonucleotide aptamer-drug conjugates for targeted therapy of acute myeloid leukemia

    Oligonucleotide aptamer-drug conjugates for targeted therapy of acute myeloid leukemia Autor Nianxi Zhao, Sung-Nan Pei, Jianjun Qi, Zihua Zeng, Swaminathan P. Iyer, Pei Lin, Ching‐Hsuan Tung, Youli Zu

    Vydáno 2015
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  7. 7
    The novel Aurora A kinase inhibitor MLN8237 is active in resistant chronic myeloid leukaemia and significantly increases the efficacy of nilotinib

    The novel Aurora A kinase inhibitor MLN8237 is active in resistant chronic myeloid leukaemia and significantly increases the efficacy of nilotinib Autor Kevin R. Kelly, Jeffrey Ecsedy, Ernest Medina, Devalingam Mahalingam, Swaminathan P. Iyer, Steffan T. Nawrocki, Francis J. Giles, Jennifer S. Carew

    Vydáno 2010
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  8. 8
    Mycobacterial infections due to PD-1 and PD-L1 checkpoint inhibitors

    Mycobacterial infections due to PD-1 and PD-L1 checkpoint inhibitors Autor Kartik Anand, Geetanjali Sahu, Ethan Burns, Allyne M. Ensor, Joe Ensor, Sai Ravi Pingali, Vivek Subbiah, Swaminathan P. Iyer

    Vydáno 2020
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  9. 9
    Allogeneic Vaccination With a B7.1 HLA-A Gene-Modified Adenocarcinoma Cell Line in Patients With Advanced Non–Small-Cell Lung Cancer

    Allogeneic Vaccination With a B7.1 HLA-A Gene-Modified Adenocarcinoma Cell Line in Patients With Advanced Non–Small-Cell Lung Cancer Autor Luis E. Raez, Peter A. Cassileth, James J. Schlesselman, Kasi S. Sridhar, Swaminathan P. Iyer, Eva Fisher, Paulette Baldie, Eckhard R. Podack

    Vydáno 2004
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  10. 10
    T-cell lymphoma secondary to checkpoint inhibitor therapy

    T-cell lymphoma secondary to checkpoint inhibitor therapy Autor Kartik Anand, Joe Ensor, Sai Ravi Pingali, Patrick Hwu, Madeleine Duvic, Stephen Chiang, Roberto N. Miranda, Youli Zu, Swaminathan P. Iyer

    Vydáno 2020
    Získat plný text Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  11. 11
    Targeting Aurora A kinase activity with the investigational agent alisertib increases the efficacy of cytarabine through a FOXO‐dependent mechanism

    Targeting Aurora A kinase activity with the investigational agent alisertib increases the efficacy of cytarabine through a FOXO‐dependent mechanism Autor Kevin R. Kelly, Steffan T. Nawrocki, Claudia M. Espitia, Mengkun Zhang, Johnny Yang, Swaminathan P. Iyer, Jeffrey Ecsedy, Francis J. Giles, Jennifer S. Carew

    Vydáno 2012
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  12. 12
    Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells

    Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells Autor Warren Fiskus, S. Sharma, Biren Shah, Bryce P. Portier, Santhana G.T. Devaraj, Kathy Liu, Swaminathan P. Iyer, David J. Bearss, Kapil N. Bhalla

    Vydáno 2014
    Získat plný text
    Errata/Corrigenda
    Přidat do oblíbených
    Uloženo v:
  13. 13
    A pilot study to evaluate home-based screening for the common non-communicable diseases by a dedicated cadre of community health workers in a rural setting in India

    A pilot study to evaluate home-based screening for the common non-communicable diseases by a dedicated cadre of community health workers in a rural setting in India Autor Partha Basu, Manoj Mahajan, Nilesh Patira, Sangita Prasad, Sushma Mogri, Richard Muwonge, Eric Lucas, Rengaswamy Sankaranarayanan, Swaminathan P. Iyer, Navami Naik, Kirti Jain

    Vydáno 2019
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  14. 14
    Pharmacokinetic study of omacetaxine mepesuccinate administered subcutaneously to patients with advanced solid and hematologic tumors

    Pharmacokinetic study of omacetaxine mepesuccinate administered subcutaneously to patients with advanced solid and hematologic tumors Autor John Nemunaitis, Alain C. Mita, Joe Stephenson, Monica Mita, John Sarantopoulos, Swaminathan P. Iyer, Nisha Nanda, Lyon L. Gleich, Annie-Claude Benichou, Adam Craig

    Vydáno 2012
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  15. 15
    Pre-clinical efficacy of combined therapy with novel β-catenin antagonist BC2059 and histone deacetylase inhibitor against AML cells

    Pre-clinical efficacy of combined therapy with novel β-catenin antagonist BC2059 and histone deacetylase inhibitor against AML cells Autor Warren Fiskus, S. Sharma, Saikat Saha, Biren Shah, Santhana G.T. Devaraj, Baohua Sun, Stephen Horrigan, Christopher Leveque, Youli Zu, Swaminathan P. Iyer, Kapil N. Bhalla

    Vydáno 2014
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  16. 16
    SMARCAD1 Phosphorylation and Ubiquitination Are Required for Resection during DNA Double-Strand Break Repair

    SMARCAD1 Phosphorylation and Ubiquitination Are Required for Resection during DNA Double-Strand Break Repair Autor Sharmistha Chakraborty, Raj K. Pandita, Shashank Hambarde, Abid R. Mattoo, Vijaya Charaka, Kazi Mokim Ahmed, Swaminathan P. Iyer, Clayton R. Hunt, Tej K. Pandita

    Vydáno 2018
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  17. 17
    BET Protein Antagonist JQ1 Is Synergistically Lethal with FLT3 Tyrosine Kinase Inhibitor (TKI) and Overcomes Resistance to FLT3-TKI in AML Cells Expressing FLT-ITD

    BET Protein Antagonist JQ1 Is Synergistically Lethal with FLT3 Tyrosine Kinase Inhibitor (TKI) and Overcomes Resistance to FLT3-TKI in AML Cells Expressing FLT-ITD Autor Warren Fiskus, Sunil Sharma, Jun Qi, Bhavin Shah, Santhana G.T. Devaraj, Christopher Leveque, Bryce P. Portier, Swaminathan P. Iyer, James E. Bradner, Kapil N. Bhalla

    Vydáno 2014
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  18. 18
    Tumor flare reaction associated with lenalidomide treatment in patients with chronic lymphocytic leukemia predicts clinical response

    Tumor flare reaction associated with lenalidomide treatment in patients with chronic lymphocytic leukemia predicts clinical response Autor Asher Chanan‐Khan, Kena C. Miller, David Lawrence, Swaminathan P. Iyer, Austin Miller, Francisco Hernandez‐Illatazurri, Myron S. Czuczman, Paul K. Wallace, Jerome B. Zeldis, Kelvin H. Lee

    Vydáno 2010
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  19. 19
    Safety of CAR T-cell therapy in kidney transplant recipients

    Safety of CAR T-cell therapy in kidney transplant recipients Autor Omar Mamlouk, Ranjit Nair, Swaminathan P. Iyer, Angelina Edwards, Sattva S. Neelapu, Raphaël Steiner, Sherry Adkins, Misha Hawkins, Neeraj Saini, Kartik Devashish, Paolo Strati, Sreedhar Mandayam, Sairah Ahmed

    Vydáno 2020
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  20. 20
    Ganciclovir Inhibits Lymphocyte Proliferation by Impairing DNA Synthesis

    Ganciclovir Inhibits Lymphocyte Proliferation by Impairing DNA Synthesis Autor Minoo Battiwalla, Yiyuan Wu, Rajinder Bajwa, Marija Radovic, Nikolaos G. Almyroudis, Brahm H. Segal, Paul K. Wallace, Ryotaro Nakamura, Swaminathan P. Iyer, Theresa Hahn, Philip L. McCarthy

    Vydáno 2007
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:

Vyhledávací nástroje: